Artificial Organs Market – By Organ Type, By Material Type– Global Forecast, 2025 – 2034

Artificial Organs Market Size

The global artificial organs market size was valued at USD 35.3 billion in 2024 and is expected to reach USD 91 billion in 2034, growing at a CAGR of 10% from 2025 to 2034. An artificial organ is a manmade device or tissue, that is implanted or integrated into a human body to replace a natural organ, duplicate a function, or augment a specific function. The main goal is to allow the patient to return to a normal life as soon as possible. It may be integrated for a lifetime or for a specific period.
 

The scarcity of organ donors is rising globally. The primary factor is owing to the increasing demand for organ transplants in comparison to the donors available. For instance, according to the Health Resources & Services Administration (HRSA), 103,223 people were awaiting for their organ transplants as of 2023. Further, HSRA has also stated that 17 people are dying every day as they wait for their name to arrive in the list of organ transplants. Thus, there exists a huge gap between availability of organ donors and the requirement of the organ transplantations which is motivating the key players in this market to develop innovative products.
 

Moreover, the surge in the elderly population is creating a demand for artificial organs worldwide. The United Nations (UN) estimates that the world population aged 65 years and above is expected to reach 1.6 billion by 2050, which is nearly twice the 761 million from 2021. Moreover, older adults are more prone to require an organ transplant. According to the Health Resources & Services Administration (HSRA), in 2023, about 64% of all the people that received organ transplants were 50 years or older and over 23% of all receiving patients were 65 years or older in the U.S. Thus, the increasing elderly population is thereby anticipated to boost the market growth.
 

 Artificial Organs Market Trends

• The progress in obtaining regulatory approval on artificial organs alongside the emergence of new technologies including 3D bioprinting, has spurred high demand for transplant products. 3D bioprinting, which is expected to reach USD 6.5 billion in 2032, is capable of tissue and organ regeneration. For instance, in June 2021, Readily3D announced that they are developing a 3D-printed living model of the pancreas for diabetes medicine testing as part of the EU funded Enlight project.
   
• Furthermore, manufacturers are entering the market by expanding their portfolio to provide more comprehensive and innovative products. For instance, in December 2023, Carmat announced the first implantation of their Aeson heart in a patient suffering from a cardiac tumor. In February 2021, Aeson, the Carmat Total Artificial Heart was approved by the U.S. Food and Drug Administration (FDA) for beginning enrollment in the early feasibility study (EFS) in the U.S.
   
• In addition to this, organizations are hosting events wherein all the key players and aspiring manufacturers can participate and exchange knowledge in this field. For instance, Advanced Organ Bioengineering and Therapeutics (AOT) group is hosting an event ESAO 2025, from June 25-28, in Netherlands, featuring discussions on the latest advancements in bioartificial organs. Such platforms are promoting the growth of this market.
   
• Additionally, there is an increasing trend of incorporating artificial intelligence and machine learning technologies to improve donor-recipient matching which will lead to more precise organ allocation and improved transplant success rates.
   

Artificial Organs Market Analysis

Based on organ type, the market is segmented into artificial kidney, artificial liver, artificial lungs, artificial pancreas, artificial heart, and other organ types. The global market for artificial organs was valued at USD 32.2 billion in 2023. The artificial kidney segment dominated the market with the largest revenue of USD 19.6 billion in 2024.
 

• The artificial kidney segment held the highest market share in the entire artificial organ’s market due to the rising prevalence of chronic kidney disease (CKD) as well as end-stage renal disease (ESRD).
   
• The rising number of patients with kidney failure drives the demand for this segment. The National Kidney Foundation estimates that more than 10 percent of people around the world are suffering from chronic kidney disease (CKD). Moreover, the U.S. performs a large number of kidney transplants which emphasizes the need of innovative renal care solutions.
   
• According to the United Network for Organ Sharing, in the U.S. over 25,498 kidney transplants were done in 2022 alone. The number was 3.4% greater than 2021.
   
• The mobile quality of life for patients with artificial kidneys is markedly improved as there is less dependency on dialysis.
   
• In addition, constant blood filtration is carried out, which diminishes the complication further. The increasing burden of kidney related diseases along with lack of donor organs continues to stimulate the growth of the segment.
   

Based on material type, the artificial organs market is segmented into silicon, plastic, steel, and other material types. The silicon segment emerged as a dominant segment in the market accounting for 36.2% of revenue share in 2024 and is expected to reach by USD 34.7 billion in 2034.
 

• The market is majorly held by the silicon segment owing to its superior biocompatibility, flexibility, and durability. Therefore, it is very useful in the manufacturing of prosthetic limbs, cochlear implants, and even artificial hearts.
   
• Moreover, the increasing demand for biomaterials is fueling the demand for this segment in the market.
   
• Silicon-based artificial organs offer reduced rejection risks and improve patient outcomes. For instance, the medical grade silicone material enables the SynCardia Total Artificial Heart to replicate natural heart functions. Also, Cochlear Nucleus implants utilizes silicone to help patients with hearing problems.
   
• Thus, the superior properties of this material are supporting the growth of this market.
   

North America: The U.S. artificial organs market revenue has increased considerably from USD 11.7 billion in 2023 and is expected to grow significantly, reaching USD 32.3 billion by 2034.
 

• The U.S. has a growing burden of chronic diseases such as CKD as well as ESRD, which are impacting quality of life of the residents. Moreover, the high rate of kidney transplants in the country is further propelling the market.
   
• For instance, according to the HSRA, in 2023, a total of 46,632 organ transplants were made using both living and deceased donors. This marks an increase of 8.7% compared to 2022 and an increase of 12.7% over 2021.
   
• Such statistics are pushing the key players to improve their capabilities in the production of artificial organs, thus fostering market growth.
   

Europe: The UK artificial organs industry is projected to experience steady growth between 2025 and 2034.
 

• The number of kidney transplant cases in the UK are quite high. According to the data from Statista, the UK has a relatively high rate of kidney transplants in comparison to most European Union countries. Statista estimates that in 2023-24, around 3,717 organ transplants took place in the UK.
   
• Further, the rate of kidney transplants specifically was 46.6 per million population in 2022. This was the sixth highest in Europe. Thus, market is estimated to grow in the near future considering such aforementioned statistics.
   
• Further, the aging population in the UK is another fundamental reason for the expansion of the market since people aged 65 and above are likely to suffer from chronic diseases and further might require organ transplants.
   

Asia Pacific: Japan artificial organs market is poised to witness lucrative growth between 2025 – 2034.
 

• With Japan undergoing huge demographic transitions, It is expected that Japan will have a high burden of disease, and subsequently, an acceleration in the growth and technological advancement in the field of artificial organs will materialize.
   
• As of November 2023, Statista reports that over 36.35 million people in Japan are over 65 years old.
   
• Moreover, according to the data published in the article ‘Organ donation after cardiac death in Japan’, since the Organ Transplant Law amendment in July 2010, the rate of donation after Cardiac Death (DCD), which was mostly associated with kidney transplantation, has fallen off during the past decade. Between 2009 and 2019, DCD donors underwent a drastic reduction from 98 to 28, the reason for which remained rather obscure.
   
• Such declining availability of donors in the country underscores a need for artificial organs in the country.
   

Middle East and Africa: The artificial organs market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• Saudi Arabia faces high burden of CKD as well as ESKD, and the country also has an aging population. For instance, the number of people aged 60 and above are expected to rise five times from 2 million (5.9% of the total population) in 2020, reaching 10.5 million by 2050.
   
• Moreover, according to the data published by an open access journal, the total number of patients with chronic renal failure reached 21,000 in Saudi Arabia in 2023 which was approximately 9,600 a decade ago.
   
• Such high trends in the aging population as well as organ failures are expected to increase the demand for artificial organs in coming years
   

Artificial Organs Market Share

The top 4 competitors in the artificial organs sector are Abiomed, Medtronic, SynCardia Systems, and Edwards Lifesciences. These players held a significant share of approximately 40% in the market These organizations are involved in clinical advancements and product innovations. They are also strategically partnering with the organizations such as research institutions and healthcare organizations.
 

Moreover, emerging players are developing novel solutions, including biocompatible artificial hearts, fully implantable artificial kidneys, and bioengineered lung technologies. These innovations, along with rising healthcare investments and increasing organ failure cases, are driving market growth.
 

 Artificial Organs Market Companies

Some of the eminent market participants operating in the artificial organs industry include:

• ABIOMED
• Berlin Heart
• Boston Scientific
• Cochlear
• Edwards Lifesciences
• Ekso Bionics
• Jarvik Heart
• Medtronic
• SynCardia Systems
• Zimmer Biomet

• Abiomed is a key player in the field of heart recovery and support systems. The company has gained a significant market share with its flagship product - Impella heart pump.
   
• Berlin Heart holds a considerable market share in this market and is the only company that offers systems suitable for all ages, from newborns to adults. The company has developed EXCOR ventricular assist device (VAD). It is available for adults as well as pediatrics, making the company a key player in the market.
   
• SynCardia Systems has its expertise in mechanical circulatory support segment and is a leading player in this market. The company offers the only FDA- and Health Canada-approved Total Artificial Heart (TAH) available commercially.
   

Artificial Organs Industry News:

• In November 2023, BiVACOR, Inc., announced that it has received the FDA approval for the BiVACOR Total Artificial Heart (BTAH) to start an investigational device exemption (IDE) for the first-in-human EFS. Such regulatory approvals are contributing to the progression of this market.
   
• In March 2022, Edwards Lifesciences reported that it had received clearance from the Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a custom tissue valve prosthesis for the mitral position of the heart. The valve can now also be kept in dry packaged conditions, making it easier to store and more useful. This marvel demonstrated Edward Lifesciences' dedication to providing advanced solutions in cardiac care.
   

The artificial organs market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Organ Type

• Artificial kidney
• Artificial liver
• Artificial lungs
• Artificial pancreas
• Artificial heart
• Other organ types

Market, By Material Type

• Silicon
• Plastic
• Steel
• Other material types  

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE